ARVN PEER ANALYSIS

Arvinas Inc — metric-by-metric comparison with peers and the industry median

ARVNArvinas Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

ARVNIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ARVN	MSB	TLX	RTALB	Ind. Median
P/E	—	—	—	4.89	17.81
P/B	1.40	—	6.56	0.61●	3.49
EV/EBITDA	—	—	123.31	74.61●	14.92
P/S	6.05	31.91	3.34●	6.67	10.89

Financial Health
Metric	ARVN	MSB	TLX	RTALB	Ind. Median
Current Ratio	5.44●	—	1.43	1.21	5.90
Debt/Equity	2.2%	—	112.3%	1.2%●	10.9%
NetDebt/EBITDA	2.80	—	13.13	0.90●	1.15

Profitability
Metric	ARVN	MSB	TLX	RTALB	Ind. Median
Net Margin	-247.5%	-115.3%	-0.9%	136.3%●	-125.7%
ROE	-42.3%	-11.3%	-1.8%	15.1%●	-47.5%
ROA	-26.8%	-8.6%	-0.7%	13.1%●	-35.8%
EBITDA Margin	-242.2%	-76.6%	3.0%	9.0%●	-105.8%

Growth + Dividend
Metric	ARVN	MSB	TLX	RTALB	Ind. Median
Rev. Growth	-79.1%	410.4%●	56.3%	24.0%	5.1%
NI Growth	—	—	—	134.0%	12.1%
Div. Yield	—	0.0%●	—	0.0%●	0.2%
Payout	—	0.0%	—	0.0%	0.0%

Valuation
Metric	ARVN	PRTA	AURA	XFOR	ALLO	ZURA	Ind. Median
P/E	—	—	—	—	—	—	17.81
P/B	1.40●	1.64	4.46	3.02	1.80	2.77	3.49
EV/EBITDA	—	—	—	—	—	—	14.92
P/S	6.05●	8.87	—	56.46	—	—	10.89

Financial Health
Metric	ARVN	PRTA	AURA	XFOR	ALLO	ZURA	Ind. Median
Current Ratio	5.44	10.43	7.09	10.18	9.65	19.33●	5.90
Debt/Equity	2.2%●	2.4%	15.8%	45.9%	29.1%	—	10.9%
NetDebt/EBITDA	2.80	4.31	0.88●	1.74	1.16	—	1.15

Profitability
Metric	ARVN	PRTA	AURA	XFOR	ALLO	ZURA	Ind. Median
Net Margin	-247.5%●	-260.9%	—	-1,106.3%	—	—	-125.7%
ROE	-42.3%	-40.3%●	-95.6%	-104.2%	-52.3%	-42.5%	-47.5%
ROA	-26.8%●	-35.8%	-76.7%	-49.8%	-38.4%	-37.6%	-35.8%
EBITDA Margin	-242.2%	-129.0%●	—	-996.8%	—	—	-105.8%

Growth + Dividend
Metric	ARVN	PRTA	AURA	XFOR	ALLO	ZURA	Ind. Median
Rev. Growth	-79.1%	-58.0%●	-100.0%	-71.3%	—	-100.0%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ARVN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.